CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Tapimmune Inc.

For profitContributed to NMEWebsite ↗
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jul 1, 2012

Last known activity

Jan 26, 2017

Acquired by Marker Therapeutics on May 15, 2018

Timeline

1990s

  1. Jun 1, 1999

    Tapimmune Inc.— Founded

2010s

  1. May 15, 2018

    Marker Therapeutics— Acquired By

Drugs by trial phase (7 distinct, 4 trials)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

Details

Founded
Jacksonville, FL, US Jun 1, 1999
Last known activity
Jan 26, 2017